Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector ...
Preservative Free Methotrexate Injection, USP 1g by APP APP has received approval from the FDA to market preservative-free methotrexate injection. APP has received approval from the FDA to market ...
Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. FDA has accepted Eisai's Biologics License Application for lecanemab-irmb, marketed as LEQEMBI, which is designed for subcutaneous ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback